Some news on lung cancer treatments from the European Society for Medical Oncology (or ESMO):
- A new immunotherapy (atezolizumab or Tecentriq) improved survival vs chemo as second-line therapy for patients with NSCLC. This drug could be FDA-approved by October 19.
- Pembrolizumab (Keytruda) improved survival vs chemo as first-line therapy in patients with NSCLC if they had high levels of the biomarker PD-L1. Pembrolizumab is already approved as second-line therapy (for NSCLC), but could be FDA-approved as first-line therapy by December 24.
Written by
MFH_Advocate
To view profiles and participate in discussions please or .
I have been fighting lung cancer and just had my 5 year anniversary. I have had surgery, chemo, cyber knife radiation more chemo and now on Opdivo. I was diagnosed with stage 4 but it has not moved from my lungs. Prayer from so many people and my I don't give up attitude have helped me on my way. Stat positive and hopefully in the neat future they will find a cure
How are u stage 4 if only in lung.I too have stage4 nsclc had l/3 out 2 1/2 yes ago mi b e came back 1 yr yo lymph nodes abd brain had radiation on chest and lymph nodes. 3 gamma knivesfor brain met .been on optivo for 6 months no growth or movement in,last 3 chest scans praying for all cancer fighters
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.